EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
90 hedge funds and large institutions have $196M invested in Eiger BioPharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
5% less capital invested
Capital invested by funds: $207M → $196M (-$11.1M)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
Holders
90
Holding in Top 10
2
Calls
$4.08M
Puts
$803K
Top Buyers
| 1 | +$9.07M | |
| 2 | +$2.27M | |
| 3 | +$1.1M | |
| 4 |
Morgan Stanley
New York
|
+$519K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$489K |
Top Sellers
| 1 | -$7.88M | |
| 2 | -$3.47M | |
| 3 | -$1.4M | |
| 4 |
Two Sigma Investments
New York
|
-$1.23M |
| 5 |
Millennium Management
New York
|
-$1.19M |